Clinical Trial Update: Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of bortezomib and clofarabine in adults with relapsed solid tumors has been completed. The listed conditions include …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphomas
• Myelodysplastic Syndromes
• Neoplasms

Drugs mentioned

• Clolar (Clofarabine)
• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED